U.S GOVERNMENT SIGNS A DEAL WITH REGENERON PHARMACEUTICALS

Highlights –

• U.S Government signs a deal with Regeneron Pharmaceuticals.
• A $450 million contract has been signed between the two parties.
• The deal is for supplying a double antibody cocktail drug for COVID-19.
• The name of the drug is REGN-COV2.

The U.S government has signed a deal with Regeneron Pharmaceuticals Inc. (REGN.O). On Tuesday, the U.S Departm....